Milliman, Inc., a premier global consulting and actuarial firm, today announced plans by Milliman Financial Risk Management ...

A look into how Eli Lilly's growth and large weightings are influencing major pharma ETFs, leaving investors more exposed to ...

For investors seeking momentum, State Street SPDR S&P Biotech ETF XBI is probably on the radar. The fund just hit a 52-week high and rose 73.06% from its 52-week low price of $66.66/share. But, are ...

November marks National Alzheimer’s Disease Awareness Month in the United States, serving as a crucial reminder of the millions affected by the disease. This observance, established in 1983, has ...

Designed to provide broad exposure to the Health Care ETFs category of the market, the First Trust Health Care AlphaDEX ETF (FXH) is a smart beta exchange traded fund launched on 05/08/2007. What Are ...

FHLC is a solid healthcare ETF, but VHT offers slightly better performance, liquidity, and diversification for a similar expense ratio. FHLC’s high concentration in top holdings and lower trading ...

The S&P 500 Healthcare sector (XLV) experienced a slight rise in average short interest during October, moving from 1.91% to ...

T. Rowe Price Expands ETF Lineup With 3 Actively Managed Sector Picks Across Key Sectors T. Rowe Price launches 3 new actively managed ETFs with lower costs, providing diversified, research-based ...

A boom in major U.S. pharmaceutical stocks is creating a swarm of activity around an exchange-traded fund tracking the massive drug makers. The $8.2 billion Vanguard Health Care ETF, known by its ...

The First Trust Health Care AlphaDEX ETF (FXH) made its debut on 05/08/2007, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. For a ...